PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24804016-6	2013	Gene expression results in HUVEC showed that cinnamon extract treatment inhibited TPA induction of protein kinase C, PKCalpha and PKCeta messenger RNA (mRNA) expression in a dose-dependent manner along with suppression of vascular endothelial growth factor receptor 1 (VEGFR1/Flt1) and vascular endothelial growth factor receptor 2 (VEGFR2/KDR/Flk1) mRNA expression.	Tetradecanoylphorbol Acetate	82-85	fms related receptor tyrosine kinase 1	Homo sapiens	269-275	
19205902-6	2009	PMA treatment in THP-1 cells resulted in increased expression of matrix metalloproteinase (MMP) 9 and vascular endothelial growth factor receptor 1 (VEGFR1), whereas inhibition of ATP7A resulted in suppression of PMA-induced expression of VEGFR1, but not MMP9.	Tetradecanoylphorbol Acetate	0-3	fms related receptor tyrosine kinase 1	Homo sapiens	102-147	
19205902-6	2009	PMA treatment in THP-1 cells resulted in increased expression of matrix metalloproteinase (MMP) 9 and vascular endothelial growth factor receptor 1 (VEGFR1), whereas inhibition of ATP7A resulted in suppression of PMA-induced expression of VEGFR1, but not MMP9.	Tetradecanoylphorbol Acetate	0-3	fms related receptor tyrosine kinase 1	Homo sapiens	149-155	
19205902-6	2009	PMA treatment in THP-1 cells resulted in increased expression of matrix metalloproteinase (MMP) 9 and vascular endothelial growth factor receptor 1 (VEGFR1), whereas inhibition of ATP7A resulted in suppression of PMA-induced expression of VEGFR1, but not MMP9.	Tetradecanoylphorbol Acetate	0-3	fms related receptor tyrosine kinase 1	Homo sapiens	239-245	
8630024-8	1996	However, flt-1, flt-4 and KDR transcript levels were enhanced following treatment with tetradecanoylphorbol acetate.	Tetradecanoylphorbol Acetate	87-115	fms related receptor tyrosine kinase 1	Homo sapiens	9-14